Adagene (ADAG) Operating Leases (2022 - 2026)
Adagene (ADAG) posted quarterly Operating Leases of $53.5 billion for Q4 2025, down 62.42% year-over-year from $142.3 billion in Q4 2024, and up 60289624.37% quarter-over-quarter from $88705.0 in Q2 2025.
Analysis
Adagene (ADAG) Operating Leases (2022 - 2026) Analysis & Trends
Adagene (ADAG) has reported Operating Leases for 4 consecutive years, with $53.5 billion the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Leases fell 62.42% year-over-year to $53.5 billion; the TTM figure through Dec 2025 stood at $53.5 billion (down 62.42% YoY), while the FY2025 annual figure was $53.5 billion, down 62.42% from the prior year.
- Operating Leases grew to $53.5 billion in Q4 2025 per ADAG's latest filing, from $88705.0 in the prior quarter.
- Across five years, Operating Leases topped out at $173.7 billion in Q4 2023 and bottomed at $88705.0 in Q2 2025.
- Historically, Operating Leases has averaged $86.6 billion across 4 years, with a median of $91.0 billion in 2022.
- Annual changes were most pronounced in 2023 — Operating Leases surged 222.58% — and 2024, when it sank 100.0%.
- Adagene's Operating Leases stood at $53.8 billion in 2022, then soared by 222.58% to $173.7 billion in 2023, then fell by 18.06% to $142.3 billion in 2024, then slumped by 62.42% to $53.5 billion in 2025.
- Business Quant data shows ADAG's Operating Leases at $53.5 billion in Q4 2025, $88705.0 in Q2 2025, and $142.3 billion in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Adagene | 211.24 Mn | 211.24 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 183,189.00 |
| Dec 31, 2025 | 53,480.00 |
| Jun 30, 2025 | 88,705.00 |
| Dec 31, 2024 | 142,304.00 |
| Jun 30, 2024 | 114,086.00 |
| Dec 31, 2023 | 173,660.00 |
| Jun 30, 2023 | 141,431.00 |
| Dec 31, 2022 | 53,834.00 |
| Jun 30, 2022 | 128,083.00 |